Article
Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infections
31 Jul 2020
Abstract excerpt
AIMS: To investigate the 1-year risks of Staphylococcus aureus bacteraemia (SAB), sepsis, and pneumonia in patients who underwent percutaneous coronary intervention and were treated with ticagrelor vs. clopidogrel. METHODS AND RESULTS: In this nationwide observational cohort study, 26 606 patients who underwent urgent or emergent percutaneous coronary intervention (January 2011-December 2017) and initiated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
